CLS vs FLEX: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
CLS (Celestica) and FLEX (Flex Ltd) share investment themes but are different businesses. The right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme.
CLS vs FLEX: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | CLS | FLEX | What it tells you |
|---|---|---|---|
| Market cap | $38.11B | $41.68B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 16.70 | 16.06 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 36.38 | 43.92 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 1.51 | 1.63 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 53% of range | 55% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 15.37 | 7.73 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how CLS and FLEX affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CLS and FLEX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CLS and FLEX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Celestica (CLS) do?
Celestica is a Toronto-based electronics manufacturing services (EMS) and supply-chain company that designs, builds, and tests hardware for other companies. It reports in two segments. Connectivity & Cloud Solutions (CCS) is the larger and faster-growing one, serving data-center and communications customers with networking switches, servers, storage, and increasingly custom AI/ML compute hardware; in Q1 2026 CCS was about ~80% of total revenue and grew roughly ~76% year over year, with hyperscaler customers making up the majority of that segment. Advanced Technology Solutions (ATS) is the diversified segment covering aerospace and defense, industrial, HealthTech, and capital equipment. The company makes money on the volume and complexity of the hardware it manufactures and on higher-value design and joint-design-manufacturing (JDM) work, where margins are structurally better than commodity contract assembly.
What does Flex Ltd (FLEX) do?
Flex Ltd is a global electronics manufacturing services (EMS) company, effectively an outsourced factory and supply chain that designs and builds products for other brands. It is consistently ranked among the largest EMS providers in the world by revenue, competing near the top of the industry with fiscal-year revenue in the mid-$20 billions. Flex reports across segments including Flex Agility Solutions and Flex Reliability Solutions, serving end markets that span cloud and data-center infrastructure, automotive, industrial, healthcare, and energy. Because it manufactures on contract, its margins are structurally thin compared with the brands it serves, and the investment case turns on volume, efficiency, and moving into higher-value services like design, power products, and data-center integration.
CLS vs FLEX: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- CLS drivers: Hyperscaler-driven CCS growth; AI networking and compute content.
- FLEX drivers: Data-center and AI infrastructure demand; Margin-mix shift toward higher-value work.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. For FLEX, the dominant risk is that EMS is a low-margin, high-volume business, so thin margins leave little room for error and any operational stumble or pricing pressure hits profit quickly.
CLS or FLEX: which should you pick?
CLS vs FLEX: the full fundamentals
CLS. These figures are tied to the June 2026 reporting picture and Celestica's Q1 2026 results announced in late April 2026. The company has repeatedly beaten and raised guidance on AI-driven demand, and its valuation multiple has expanded well above its historical EMS range to reflect those growth expectations. A premium multiple means the stock is more sensitive to any disappointment in growth or margins than a traditional contract manufacturer would be.
FLEX. Figures are approximate and tied to the asOf date; verify live numbers before acting. For a contract manufacturer, revenue is large but margins are thin, so profit and free cash flow matter more than headline sales, and the valuation debate centers on whether the mix shift into data-center and higher-margin work justifies a higher multiple than a traditional low-margin EMS name. Comparisons to peers like Jabil and Celestica on forward earnings and margin trajectory are usually more informative than an absolute multiple.
Headline figures (approximate, June 2026): CLS shows q1 2026 revenue ~$4.05B (up ~53% YoY), ccs segment growth ~76% YoY in Q1 2026 (~80% of revenue), 2026 revenue guidance ~$19B (raised from ~$17B), adjusted operating margin ~8.0% Q1 2026; ~8.1% 2026 guide; FLEX shows revenue Recent quarterly revenue in the high-$6 billion range; annual revenue in the mid-$20 billions (approximate; verify live), earnings trend Has beaten adjusted EPS estimates in most recent quarters, helped by data-center demand, margins Structurally thin EMS gross margins (roughly high single digits); operating margin is the key improvement metric, market cap Roughly low-to-mid $20 billions (approximate; verify live).
The bottom line: CLS vs FLEX
CLS and FLEX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CLS and FLEX exposure against your real portfolio. It is not an investment adviser.
Wondering how CLS or FLEX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Celestica with AI
Connect the broker you already use and ask Walnut's AI how CLS fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between CLS and FLEX?
+
Celestica is a Toronto-based electronics manufacturing services (EMS) and supply-chain company that designs, builds, and tests hardware for other companies. Flex Ltd is a global electronics manufacturing services (EMS) company, effectively an outsourced factory and supply chain that designs and builds products for other brands. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is CLS or FLEX the better stock?
+
Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, CLS or FLEX?
+
On forward P/E (as of August 2026), CLS trades at 16.70x and FLEX at 16.06x, so FLEX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both CLS and FLEX?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of CLS vs FLEX?
+
CLS: Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. EMS has historically run thin margins, leaving limited cushion if pricing or volumes compress. The business is tied to AI capital spending, which is cyclical and could slow or pause after a heavy buildout phase. And the stock has re-rated to a much higher multiple than its EMS history, so it carries both competition from Jabil, Flex, Foxconn, and ODMs and the risk that high growth expectations are not met. FLEX: The dominant risk is that EMS is a low-margin, high-volume business, so thin margins leave little room for error and any operational stumble or pricing pressure hits profit quickly. Customer concentration is a structural risk: losing or seeing a slowdown at a few large customers can materially dent revenue. Flex is exposed to the broader electronics and manufacturing cycle, so a downturn in demand across cloud, automotive, or industrial markets would pressure volumes. As a global manufacturer, it faces tariff, trade-policy, and supply-chain risks, including component shortages and the cost of shifting production across regions. The data-center tailwind is powerful but also a concentration bet: if hyperscaler capital spending on AI infrastructure slows, a big source of recent upside could fade. Finally, contract manufacturers have limited pricing power against the brands they serve, which caps how much margin expansion is realistically achievable.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CLS or FLEX; figures are approximate and dated (as of August 2026). Verify current data before investing.